英特尔助推智慧医疗:求医“新规则”,不出千里看专家

2017-06-13 佚名 英特尔

健康数据管理平台更是为医疗卫生服务提供了系统、全面的支撑。英特尔联合纳里健康推出全新分级诊疗云平台,助推智慧医疗。 /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; col

随着分级诊疗越来越步入正轨,过去病人无论大病小病,都宁可在三甲医院找专家就诊的旧观念如今也在转变,传统的就医理念和模式正逐步被打破。随着互联网技术的不断冲击,大量的移动医疗APP出现,分级导诊也被推上历史平台,通过“互联网+”,患者足不出户就可以得到大医院专家的医疗服务,基层转专诊只需“点点鼠标”便可在十几分钟内完成。健康数据管理平台更是为医疗卫生服务提供了系统、全面的支撑。英特尔联合纳里健康推出全新分级诊疗云平台,助推智慧医疗。

英特尔携手ISV推动智慧医疗稳定发展

纳里健康云平台作为国内首家以分级诊疗为核心的移动智慧医疗云平台,创新“互联网+医生+医院”模式,通过移动化专业诊疗服务工具,为医生提供日常所需的诊疗辅助支持;为居民提供全方位健康服务:无论是诊前还是诊后,大众都可以随时随地通过平台进行健康咨询,还能通过手机等移动设备进行预约、挂号、付费、查报告、管理自己和家人的健康档案,享受全流程的医疗健康服务。

这一切除了依托于纳里健康云平台外,还不能少了英特尔NUC迷你PC的功劳,英特尔NUC迷你PC体积非常小,只有笔记本电脑的几分之一,却提供较为完整的USB、和视频输出并运行Windows系统。这套主机功耗超低尺寸也很小,社区卫生中心的医生甚至将其放在地板上使用,无需考虑散热问题,同时也非常省电。这给需要打印机等设备且桌面资源宝贵的写字台更多空间。通过英特尔联合纳里健康推出全新分级诊疗云平台,社区医生可以把需要专家会诊的患者通过纳里云平台推荐给三级医院,利用云影像功能邀请专家共同诊疗。云影像功能包括远程影像诊断、影像信息共享及调阅。为了更好的远程诊疗过程更顺畅,英特尔和纳里健康在视频交互方面做了很多努力,包括驱动视频软件算法的驱动、视频底层的视频转换的驱动等方面,同时在线视频的播放传输对于CPU的要求非常高,英特尔NUC迷你PC中配备的CPU能够支撑四路视频同时播放及传输。居民在社区卫生服务中心拍的X光片信息,可以通过平台传送到影像中心,等上二三十分钟甚至更短的时间,由医联体上级医院放射科医师阅片诊断并审核发布报告,之后报告便会传回社区医院。这样一来,患者免去了跑大医院的路途奔波以及排队等烦恼;上级医院专家接诊了更多疑难杂症;社区医院的诊断水平提高,居民更愿意来社区就诊,真正实现了资源下沉,达到了分级诊疗的目的。

整合了纳里健康软件平台的英特尔酷睿i5 NUC(迷你PC)
整合了纳里健康软件平台的英特尔酷睿i5 NUC(迷你PC)

除了跟达内健康的合作,在整个杭州市几百个社区服务中心所采用的医疗卫生服务系统 -- 杭州市基层社区卫生服务系统,也是由英特尔的一个研究团队共同来支持的底层架构。随着PC技术的不断发展,PC已经充斥在我们生活工作中的方方面面。英特尔NUC迷你PC在性能毫不打折的前提下,拥有更小的外形,其配备的CPU相较于传统PC更能节省功耗,让用户能有更好的使用体验和使用环境,满足家庭和工作的不同需求。

移动智慧医疗云平台 助力分级诊疗做到医疗资源下沉

杭州市“医改明星单位”江干区凯旋社区卫生服务中心是接待过刘延东副总理、国家卫计委李斌主任的全国示范社区卫生服务中心。作为第一批使用纳里云平台的社区卫生服务中心,凯旋社区卫生服务中心在2016年接诊患者32万人次,其中约13%的患者被推荐到三级医院进行远程诊疗。该中心副主任姜永乐医生表示,云平台的使用受到了患者的大力支持,让患者更愿意在社区医院就诊,也更有益于慢病的预防和控制。

凯旋社区医生与杭州中心医院邵逸夫医院医生视频针对患者的病情进行交流
凯旋社区医生与杭州中心医院邵逸夫医院医生视频针对患者的病情进行交流

在凯旋街道社区卫生服务中心的二楼专门开设了一个“云诊室”,听上去很高端洋气的名号,实际上里面看起来和其他的问诊房间无二,但当你一坐到问诊台的医生面前,马上就会发现不同,这里不止是一位医生在给你看病,在问诊台上的电脑屏幕里,还有几个不同面孔的来自对口三甲医院的“白大褂”在对着你“望闻问切”,为你做出全方面的诊断。对于患者而言,纳里云平台让看病不再“烦”。无论是诊前还是诊后,大众都可以随时随地通过平台向专家进行健康咨询,还能通过手机等移动设备进行预约、挂号、付费、查报告,像医保移动支付+第三方扫码支付、咨询、查询等其他方面都可以在线上完成,提升了患者就诊过程中的感受度和参与度,让就诊秩序得到了极大地提升。

在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益。目前,国家医疗行业致力构建国家医疗中心,英特尔希望通过为合作伙伴提供支撑底层的技术,通过提升国内医院能力,来助力智慧医疗的稳步发展。未来,英特尔希望联合纳里健康云平台协同医院之间、医生之间的工作,为医生和病人继续提供包括向病人提供远程的咨询服务、签约服务、健康教育等等这些服务,逐步完善医患间的协作,发展健康管理、健康跟踪等等服务,形成完整健康管理的服务,让纳里健康云平台正成为人们身边的移动的健康管家,为居民提供全方位的移动化诊疗与健康服务。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1974054, encodeId=0db319e405470, content=<a href='/topic/show?id=3fa98e140d5' target=_blank style='color:#2F92EE;'>#英特尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87140, encryptionId=3fa98e140d5, topicName=英特尔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=838d2500169, createdName=12498cb5m13暂无昵称, createdTime=Tue Aug 22 02:22:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212330, encodeId=580b212330bd, content=非常好,满足了资源的优化使用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Jun 18 13:41:48 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1574306, encodeId=1b7615e430616, content=<a href='/topic/show?id=3c2c586e23f' target=_blank style='color:#2F92EE;'>#新规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58672, encryptionId=3c2c586e23f, topicName=新规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ca16016783, createdName=xsm923, createdTime=Thu Jun 15 04:22:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210247, encodeId=eae121024e21, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Jun 13 14:37:03 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210240, encodeId=c7a6210240c2, content=所有这些都是马爸爸的,别人先开路也无用啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Tue Jun 13 14:13:31 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210238, encodeId=e87521023847, content=了解一下,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Tue Jun 13 14:12:51 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210230, encodeId=4cd321023093, content=在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Jun 13 13:52:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1974054, encodeId=0db319e405470, content=<a href='/topic/show?id=3fa98e140d5' target=_blank style='color:#2F92EE;'>#英特尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87140, encryptionId=3fa98e140d5, topicName=英特尔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=838d2500169, createdName=12498cb5m13暂无昵称, createdTime=Tue Aug 22 02:22:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212330, encodeId=580b212330bd, content=非常好,满足了资源的优化使用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Jun 18 13:41:48 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1574306, encodeId=1b7615e430616, content=<a href='/topic/show?id=3c2c586e23f' target=_blank style='color:#2F92EE;'>#新规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58672, encryptionId=3c2c586e23f, topicName=新规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ca16016783, createdName=xsm923, createdTime=Thu Jun 15 04:22:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210247, encodeId=eae121024e21, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Jun 13 14:37:03 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210240, encodeId=c7a6210240c2, content=所有这些都是马爸爸的,别人先开路也无用啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Tue Jun 13 14:13:31 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210238, encodeId=e87521023847, content=了解一下,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Tue Jun 13 14:12:51 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210230, encodeId=4cd321023093, content=在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Jun 13 13:52:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-18 lyh994

    非常好,满足了资源的优化使用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1974054, encodeId=0db319e405470, content=<a href='/topic/show?id=3fa98e140d5' target=_blank style='color:#2F92EE;'>#英特尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87140, encryptionId=3fa98e140d5, topicName=英特尔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=838d2500169, createdName=12498cb5m13暂无昵称, createdTime=Tue Aug 22 02:22:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212330, encodeId=580b212330bd, content=非常好,满足了资源的优化使用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Jun 18 13:41:48 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1574306, encodeId=1b7615e430616, content=<a href='/topic/show?id=3c2c586e23f' target=_blank style='color:#2F92EE;'>#新规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58672, encryptionId=3c2c586e23f, topicName=新规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ca16016783, createdName=xsm923, createdTime=Thu Jun 15 04:22:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210247, encodeId=eae121024e21, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Jun 13 14:37:03 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210240, encodeId=c7a6210240c2, content=所有这些都是马爸爸的,别人先开路也无用啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Tue Jun 13 14:13:31 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210238, encodeId=e87521023847, content=了解一下,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Tue Jun 13 14:12:51 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210230, encodeId=4cd321023093, content=在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Jun 13 13:52:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-15 xsm923
  4. [GetPortalCommentsPageByObjectIdResponse(id=1974054, encodeId=0db319e405470, content=<a href='/topic/show?id=3fa98e140d5' target=_blank style='color:#2F92EE;'>#英特尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87140, encryptionId=3fa98e140d5, topicName=英特尔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=838d2500169, createdName=12498cb5m13暂无昵称, createdTime=Tue Aug 22 02:22:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212330, encodeId=580b212330bd, content=非常好,满足了资源的优化使用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Jun 18 13:41:48 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1574306, encodeId=1b7615e430616, content=<a href='/topic/show?id=3c2c586e23f' target=_blank style='color:#2F92EE;'>#新规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58672, encryptionId=3c2c586e23f, topicName=新规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ca16016783, createdName=xsm923, createdTime=Thu Jun 15 04:22:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210247, encodeId=eae121024e21, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Jun 13 14:37:03 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210240, encodeId=c7a6210240c2, content=所有这些都是马爸爸的,别人先开路也无用啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Tue Jun 13 14:13:31 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210238, encodeId=e87521023847, content=了解一下,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Tue Jun 13 14:12:51 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210230, encodeId=4cd321023093, content=在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Jun 13 13:52:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-13 中医痴

    不错的,学习了,谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1974054, encodeId=0db319e405470, content=<a href='/topic/show?id=3fa98e140d5' target=_blank style='color:#2F92EE;'>#英特尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87140, encryptionId=3fa98e140d5, topicName=英特尔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=838d2500169, createdName=12498cb5m13暂无昵称, createdTime=Tue Aug 22 02:22:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212330, encodeId=580b212330bd, content=非常好,满足了资源的优化使用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Jun 18 13:41:48 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1574306, encodeId=1b7615e430616, content=<a href='/topic/show?id=3c2c586e23f' target=_blank style='color:#2F92EE;'>#新规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58672, encryptionId=3c2c586e23f, topicName=新规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ca16016783, createdName=xsm923, createdTime=Thu Jun 15 04:22:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210247, encodeId=eae121024e21, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Jun 13 14:37:03 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210240, encodeId=c7a6210240c2, content=所有这些都是马爸爸的,别人先开路也无用啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Tue Jun 13 14:13:31 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210238, encodeId=e87521023847, content=了解一下,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Tue Jun 13 14:12:51 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210230, encodeId=4cd321023093, content=在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Jun 13 13:52:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-13 sillywu

    所有这些都是马爸爸的,别人先开路也无用啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1974054, encodeId=0db319e405470, content=<a href='/topic/show?id=3fa98e140d5' target=_blank style='color:#2F92EE;'>#英特尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87140, encryptionId=3fa98e140d5, topicName=英特尔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=838d2500169, createdName=12498cb5m13暂无昵称, createdTime=Tue Aug 22 02:22:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212330, encodeId=580b212330bd, content=非常好,满足了资源的优化使用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Jun 18 13:41:48 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1574306, encodeId=1b7615e430616, content=<a href='/topic/show?id=3c2c586e23f' target=_blank style='color:#2F92EE;'>#新规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58672, encryptionId=3c2c586e23f, topicName=新规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ca16016783, createdName=xsm923, createdTime=Thu Jun 15 04:22:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210247, encodeId=eae121024e21, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Jun 13 14:37:03 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210240, encodeId=c7a6210240c2, content=所有这些都是马爸爸的,别人先开路也无用啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Tue Jun 13 14:13:31 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210238, encodeId=e87521023847, content=了解一下,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Tue Jun 13 14:12:51 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210230, encodeId=4cd321023093, content=在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Jun 13 13:52:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-13 明心见性

    了解一下,谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1974054, encodeId=0db319e405470, content=<a href='/topic/show?id=3fa98e140d5' target=_blank style='color:#2F92EE;'>#英特尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87140, encryptionId=3fa98e140d5, topicName=英特尔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=838d2500169, createdName=12498cb5m13暂无昵称, createdTime=Tue Aug 22 02:22:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212330, encodeId=580b212330bd, content=非常好,满足了资源的优化使用, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Jun 18 13:41:48 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1574306, encodeId=1b7615e430616, content=<a href='/topic/show?id=3c2c586e23f' target=_blank style='color:#2F92EE;'>#新规#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58672, encryptionId=3c2c586e23f, topicName=新规)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2ca16016783, createdName=xsm923, createdTime=Thu Jun 15 04:22:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210247, encodeId=eae121024e21, content=不错的,学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Jun 13 14:37:03 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210240, encodeId=c7a6210240c2, content=所有这些都是马爸爸的,别人先开路也无用啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib260FNcic8ThYZTmbW36JHpvHcnIog7VbWIQjibo1kwuH9obXRJJtqHn1hYHHLG0DpIMIBVFPhBBpQOJWDk1rbib2Y/0, createdBy=d27274268, createdName=sillywu, createdTime=Tue Jun 13 14:13:31 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210238, encodeId=e87521023847, content=了解一下,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQplCaQGBmjHytXQqvsuocO2uV2lOAaJibzDafJudKToVfU12LzwArHDb4TSrmU2hk5Qxzc6icoicBK3Dg/0, createdBy=a7901968505, createdName=明心见性, createdTime=Tue Jun 13 14:12:51 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=210230, encodeId=4cd321023093, content=在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Jun 13 13:52:09 CST 2017, time=2017-06-13, status=1, ipAttribution=)]
    2017-06-13 有备才能无患

    在医疗行业持续细分的大背景下许多功能不同的应用不断被开发出来,英特尔跟医疗行业内许多软件开发商都有合作,一起优化、开发这些适应不同需求的应用,能使更多用户收益

    0

相关资讯

药明生物正式在香港联交所挂牌交易

药明生物技术有限公司(简称“药明生物”,股票代码:2269.HK)香港主板上市仪式今日在香港联合交易所隆重举行。药明康德集团董事长兼首席执行官、药明生物董事长李革博士、药明生物执行董事兼首席执行官陈智胜博士等管理层和员工代表、政商界人士和中介机构纷纷到场,共同见证药明生物的这一重要发展里程碑。

斥资1000万欧元 勃林格殷格翰建立数字实验室“BI X”

随着BI X作为一家独立子公司的成立,勃林格殷格翰将专注于在医疗健康领域从理念到试点的创新数字解决方案的突破。新公司将和勃林格殷格翰的三个业务部门(人用药品、动物保健以及生物制药)密切合作,提供一个与数据科学、敏捷软件开发以及用户体验设计等领域的专业人员进行协作的平台。勃林格殷格翰首席信息官及数字实验室主任 Michael Schmelmer 概括说:“将来BI X的员工将接受具有挑战性的任务,和

“中国器官捐献日”公众宣教活动在全国多地顺利开展

6月11日,由中国器官移植发展基金会和中国人体器官捐献管理中心联合举办的第六届中国移植运动会暨“中国器官捐献日”在北京大学邱德拔体育馆举行,全国各地的近600名器官移植术后康复患者参与了本届运动会游泳、球类、及田径等项目奖牌的角逐,成绩斐然。